1. Neuronal Signaling Metabolic Enzyme/Protease Apoptosis Immunology/Inflammation
  2. Cholinesterase (ChE) Epoxide Hydrolase TNF Receptor Interleukin Related
  3. sEH/AChE-IN-5

sEH/AChE-IN-5 is a selective, orally active and brain-penetrant acetylcholinesterase (AChE) and soluble epoxide hydrolase (sEH) dual inhibitor with IC50 values of 1.7 nM and 0.7 nM. sEH/AChE-IN-5 mediates neuroprotection and anti-inflammation via reduced TNF-α, IL-1β, IL-6, iNOS. sEH/AChE-IN-5 improves Scopolamine (HY-N0296)-induced learning and memory deficits mice. sEH/AChE-IN-5 can be used for the research of Alzheimer's disease.

For research use only. We do not sell to patients.

sEH/AChE-IN-5

sEH/AChE-IN-5 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

sEH/AChE-IN-5 is a selective, orally active and brain-penetrant acetylcholinesterase (AChE) and soluble epoxide hydrolase (sEH) dual inhibitor with IC50 values of 1.7 nM and 0.7 nM. sEH/AChE-IN-5 mediates neuroprotection and anti-inflammation via reduced TNF-α, IL-1β, IL-6, iNOS. sEH/AChE-IN-5 improves Scopolamine (HY-N0296)-induced learning and memory deficits mice. sEH/AChE-IN-5 can be used for the research of Alzheimer's disease[1].

IC50 & Target[1]

AChE

1.7 nM (IC50)

sEH

0.7 nM (IC50)

IL-1β

 

IL-6

 

In Vitro

sEH/AChE-IN-5 (Compound z43) potently inhibits recombinant hAChE with an IC50 of 1.7 nM and inhibits hBuChE with an IC50 of 942.0 nM[1].
sEH/AChE-IN-5 potently inhibits recombinant hsEH with an IC50 of 0.7 nM[1].
sEH/AChE-IN-5 (20 μM; 48 h) exhibits low cytotoxicity in HepG2, SMMC7721, and SH-SY5Y cell lines, with IC50 values of 82.27 μM, >100 μM, and >20 μM respectively[1].
sEH/AChE-IN-5 (1.25-20 μM) exhibits no significant cytotoxicity in PC12 and BV-2 cell lines at concentrations up to 20 μM[1].
sEH/AChE-IN-5 (5-20 μM; 26 h) protects PC12 cells from H2O2-induced toxicity, increasing cell viability by over 20% at 5 μM in a dose-dependent manner[1].
sEH/AChE-IN-5 (5-20 μM; 1 h pretreatment) dose-dependently reduces LPS (HY-D1056)-induced TNF-α, IL-1β, IL-6, and iNOS levels in BV-2 cells, restoring inflammatory factor levels to near normal at 20 μM[1].
sEH/AChE-IN-5 does not inhibit CYP1A2, shows moderate inhibition of CYP2C9, CYP2C19, and CYP2D6, strongly inhibits CYP3A4 (IC50 = 0.324 μM), and exhibits high BBB permeability via PAMPA (Pe = 3.33 × 10-6 cm/s)[1].
sEH/AChE-IN-5 shows high plasma protein binding in human, dog plasma, with over 99.9% bound in all tested species[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

ELISA Assay[1]

Cell Line: BV-2 cells
Concentration: 5, 10, 20 μM
Incubation Time: 1 h pretreatment before LPS
Result: Does-dependently reduces LPS-induced TNF-α, IL-1β, IL-6.
Restored inflammatory factor levels to near normal at 20 μM.
In Vivo

sEH/AChE-IN-5 (Compound z43) (5-30 mg/kg; i.g.; daily 11 days) dose-dependently improves Scopolamine (HY-N0296)-induced learning and memory deficits in male ICR mice[1].
sEH/AChE-IN-5 (30-1200 mg/kg; i.g.) exhibits favorable acute safety in female Kunming mice, with no observed organ toxicity or adverse events[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Alzheimer's disease ICR mice (male, 3-4 weeks old, 18-22 g, Scopolamine-induced cognitive impairment)[1]
Dosage: 5 mg/kg; 10 mg/kg; 30 mg/kg
Administration: I.g.; daily; 11 days
Result: Increased Scopolamine-reduced spontaneous alternation rate from 42.28% to 55.93% (5 mg/kg), 56.79% (10 mg/kg), and 59.35% (30 mg/kg) in the Y-maze test.
Maintained stable total arm entries across all groups, indicating no motor impairment.
Increased Scopolamine-reduced discrimination index from 11.80% to 21.62% (5 mg/kg), 23.82% (10 mg/kg), and 27.99% (30 mg/kg) in the novel object recognition test.
Reversed Scopolamine-elevated brain acetylcholinesterase activity in a dose-dependent manner.
Molecular Weight

660.09

Formula

C34H29ClF3N7O2

SMILES

O=C(NCC1=CC=C(C#N)C=C1C(F)(F)F)C2=CC=CC(OCC3=CN(CCNC4=C(CCCC5)C5=NC6=CC(Cl)=CC=C64)N=N3)=C2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
sEH/AChE-IN-5
Cat. No.:
HY-183341
Quantity:
MCE Japan Authorized Agent: